Zimu Wang

Fenglin Road 180
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Qiliqiangxin Improves Cardiac Glucose Metabolism After Myocardial Infarction Through a HIF-1α/MIF/AMPK Axis.

Qiliqiangxin Improves Cardiac Glucose Metabolism After Myocardial Infarction Through a HIF-1α/MIF/AMPK Axis.

Journal: Journal of cellular and molecular medicine

Published: March 11, 2026

Hexokinase HK2 regulates the MYH9-GSK3β/β-catenin axis to promote myocardial regeneration and repair after injury.

Hexokinase HK2 regulates the MYH9-GSK3β/β-catenin axis to promote myocardial regeneration and repair after injury.

Journal: European journal of pharmacology

Published: March 04, 2025

Harnessing mRNA for heart health: a new era in cardiovascular treatment.

Harnessing mRNA for heart health: a new era in cardiovascular treatment.

Journal: Theranostics

Published: February 04, 2025

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication.

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication.

Journal: Molecular biomedicine

Published: October 12, 2024

Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes.

Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes.

Journal: Life sciences

Published: June 24, 2024

Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction.

Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction.

Journal: Theranostics

Published: April 25, 2024

Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.

Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: October 04, 2023

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 20, 2022

LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.

LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.

Journal: Biochemical and biophysical research communications

Published: October 05, 2019

Combining Orthogonal Chain-End Deprotections and Thiol-Maleimide Michael Coupling: Engineering Discrete Oligomers by an Iterative Growth Strategy.

Combining Orthogonal Chain-End Deprotections and Thiol-Maleimide Michael Coupling: Engineering Discrete Oligomers by an Iterative Growth Strategy.

Journal: Angewandte Chemie (International ed. in English)

Published: June 27, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026